Letrozole in postmenopausal hormone-responsive early-stage breast cancer

被引：0

作者：

Higa, GM ^{[1
]}

机构：

[1] W Virginia Univ, Sch Pharm, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA

来源：

DRUGS | 2006年 / 66卷 / 03期

关键词：

Breast Cancer; Epidermal Growth Factor Receptor; Tamoxifen; Human Epidermal Growth Factor Receptor; Aromatase Inhibition;

D O I：

10.2165/00003495-200666030-00011

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：363 / 363

页数：1

共 50 条

[31] Standard of Care and Controversies in the Adjuvant Endocrine Treatment of Hormone-Responsive Early Breast Cancer
Bauerschlag, Dirk O.
Maass, Nicolai
Schem, Christian
[J]. BREAST CARE, 2014, 9 (04) : 283 - 286
[32] Hormone Therapy in Premenopausal Women with Early-Stage Breast Cancer
Rugo, Hope S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 175 - 176
[33] Reducing the risk of late recurrence in hormone-responsive breast cancer
Cufer, T.
[J]. ANNALS OF ONCOLOGY, 2007, 18 : 18 - 25
[34] Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer
Perez, E. A.
[J]. ANNALS OF ONCOLOGY, 2007, 18 : 26 - 35
[35] A cost-effectiveness analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with early-stage breast cancer in Mexico
Mould-Quevedo, J.
Tapia-Valencia, J.
Davila-Loaiza, G.
[J]. VALUE IN HEALTH, 2007, 10 (03) : A124 - A125
[36] Periodontal health in early-stage postmenopausal breast cancer survivors on aromatase inhibitors
Taichman, L. Susan
Inglehart, Marita
Giannobile, William
Braun, Thomas
Kolenic, Giselle
Van Poznak, Catherine
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[37] Anastrozole - A review of its use in postmenopausal women with early-stage breast cancer
Sanford, Mark
Plosker, Greg L.
[J]. DRUGS, 2008, 68 (09) : 1319 - 1340
[38] AnastrozoleA Review of its Use in Postmenopausal Women with Early-Stage Breast Cancer
Mark Sanford
Greg L. Plosker
[J]. Drugs, 2008, 68 : 1319 - 1340
[39] Treatment of Early-Stage Hormone Receptor-Positive Breast Cancer
Rugo, Hope S.
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 596 - 599
[40] Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8
Jakesz, R.
Gnant, M.
Griel, R.
Tausch, C.
Samonigg, H.
Kwasny, W.
Kubista, E.
Stierer, M.
Luschin, G.
Rueecklinger, E.
Mittlboeck, M.
[J]. CANCER RESEARCH, 2009, 69 (02) : 67S - 67S

← 1 2 3 4 5 →